Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Present at the Canaccord Genuity 37th Annual Growth Conference

DUBLIN, Ireland and TREVOSE, Pa., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
August 07, 2017 07:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Updates on KEVEYIS® Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results

~ Launched KEVEYIS® (dichlorphenamide) to U.S. Primary Periodic Paralysis Community, Established Strongbridge CareConnection Patient Services and Support Program, and Mobilized 12-Person...
July 31, 2017 07:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Host Conference Call on August 7, 2017 to Provide KEVEYIS® Launch Update and Report Second Quarter 2017 Financial Results

DUBLIN, Ireland and TREVOSE, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
July 17, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Secures $53 Million Financing From CRG

~ Financing Comprised of $50 Million Credit Facility and $3 Million Equity Investment ~~ Simultaneously Retiring Existing Debt ~~ Funds Received at Close Provide Sufficient Cash Under Current...
June 27, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Completes Target Enrollment of 90 Patients in the Phase 3 SONICS Study Evaluating RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome

DUBLIN, Ireland and TREVOSE, Pa., June 27, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
June 26, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Added to the Russell 3000® Index

DUBLIN, Ireland and TREVOSE, Pa., June 26, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
June 23, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces New Employment Inducement Awards

DUBLIN, Ireland and TREVOSE, Pa., June 23, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
June 13, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference

DUBLIN, Ireland and TREVOSE, Pa., June 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
May 25, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Present at the Jefferies 2017 Global Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., May 25, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
May 16, 2017 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Corporate Update and Reports First Quarter 2017 Financial Results

~ Strongbridge Commercial Introduction of KEVEYIS® (dichlorphenamide) in Mid-April Shows Encouraging Initial Demand ~ ~ RECORLEV™ (levoketoconazole) SONICS Study Remains on Track to Complete...